Copyright Reports & Markets. All rights reserved.

Global Melanocyte Protein PMEL Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Melanocyte Protein PMEL Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Melanocyte Protein PMEL Market Size Growth Rate by Product
      • 1.4.2 AE-M vaccine
      • 1.4.3 SCIB-1
      • 1.4.4 VPI-121
      • 1.4.5 Others
    • 1.5 Market by End User
      • 1.5.1 Global Melanocyte Protein PMEL Market Size Growth Rate by End User
      • 1.5.2 Glioblastoma Multiforme
      • 1.5.3 Melanoma
      • 1.5.4 Metastatic Melanoma
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Melanocyte Protein PMEL Market Size
      • 2.1.1 Global Melanocyte Protein PMEL Revenue 2014-2025
      • 2.1.2 Global Melanocyte Protein PMEL Sales 2014-2025
    • 2.2 Melanocyte Protein PMEL Growth Rate by Regions
      • 2.2.1 Global Melanocyte Protein PMEL Sales by Regions
      • 2.2.2 Global Melanocyte Protein PMEL Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Melanocyte Protein PMEL Sales by Manufacturers
      • 3.1.1 Melanocyte Protein PMEL Sales by Manufacturers
      • 3.1.2 Melanocyte Protein PMEL Sales Market Share by Manufacturers
      • 3.1.3 Global Melanocyte Protein PMEL Market Concentration Ratio (CR5 and HHI)
    • 3.2 Melanocyte Protein PMEL Revenue by Manufacturers
      • 3.2.1 Melanocyte Protein PMEL Revenue by Manufacturers (2014-2019)
      • 3.2.2 Melanocyte Protein PMEL Revenue Share by Manufacturers (2014-2019)
    • 3.3 Melanocyte Protein PMEL Price by Manufacturers
    • 3.4 Melanocyte Protein PMEL Manufacturing Base Distribution, Product Types
      • 3.4.1 Melanocyte Protein PMEL Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Melanocyte Protein PMEL Product Type
      • 3.4.3 Date of International Manufacturers Enter into Melanocyte Protein PMEL Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Melanocyte Protein PMEL Sales by Product
    • 4.2 Global Melanocyte Protein PMEL Revenue by Product
    • 4.3 Melanocyte Protein PMEL Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Melanocyte Protein PMEL Breakdown Data by End User

    6 North America

    • 6.1 North America Melanocyte Protein PMEL by Countries
      • 6.1.1 North America Melanocyte Protein PMEL Sales by Countries
      • 6.1.2 North America Melanocyte Protein PMEL Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Melanocyte Protein PMEL by Product
    • 6.3 North America Melanocyte Protein PMEL by End User

    7 Europe

    • 7.1 Europe Melanocyte Protein PMEL by Countries
      • 7.1.1 Europe Melanocyte Protein PMEL Sales by Countries
      • 7.1.2 Europe Melanocyte Protein PMEL Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Melanocyte Protein PMEL by Product
    • 7.3 Europe Melanocyte Protein PMEL by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Melanocyte Protein PMEL by Countries
      • 8.1.1 Asia Pacific Melanocyte Protein PMEL Sales by Countries
      • 8.1.2 Asia Pacific Melanocyte Protein PMEL Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Melanocyte Protein PMEL by Product
    • 8.3 Asia Pacific Melanocyte Protein PMEL by End User

    9 Central & South America

    • 9.1 Central & South America Melanocyte Protein PMEL by Countries
      • 9.1.1 Central & South America Melanocyte Protein PMEL Sales by Countries
      • 9.1.2 Central & South America Melanocyte Protein PMEL Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Melanocyte Protein PMEL by Product
    • 9.3 Central & South America Melanocyte Protein PMEL by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Melanocyte Protein PMEL by Countries
      • 10.1.1 Middle East and Africa Melanocyte Protein PMEL Sales by Countries
      • 10.1.2 Middle East and Africa Melanocyte Protein PMEL Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Melanocyte Protein PMEL by Product
    • 10.3 Middle East and Africa Melanocyte Protein PMEL by End User

    11 Company Profiles

    • 11.1 Antigen Express, Inc.
      • 11.1.1 Antigen Express, Inc. Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Antigen Express, Inc. Melanocyte Protein PMEL Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Antigen Express, Inc. Melanocyte Protein PMEL Products Offered
      • 11.1.5 Antigen Express, Inc. Recent Development
    • 11.2 ImmunoCellular Therapeutics, Ltd.
      • 11.2.1 ImmunoCellular Therapeutics, Ltd. Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 ImmunoCellular Therapeutics, Ltd. Melanocyte Protein PMEL Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 ImmunoCellular Therapeutics, Ltd. Melanocyte Protein PMEL Products Offered
      • 11.2.5 ImmunoCellular Therapeutics, Ltd. Recent Development
    • 11.3 Immunomic Therapeutics, Inc.
      • 11.3.1 Immunomic Therapeutics, Inc. Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Immunomic Therapeutics, Inc. Melanocyte Protein PMEL Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Immunomic Therapeutics, Inc. Melanocyte Protein PMEL Products Offered
      • 11.3.5 Immunomic Therapeutics, Inc. Recent Development
    • 11.4 Scancell Holdings Plc
      • 11.4.1 Scancell Holdings Plc Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Scancell Holdings Plc Melanocyte Protein PMEL Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Scancell Holdings Plc Melanocyte Protein PMEL Products Offered
      • 11.4.5 Scancell Holdings Plc Recent Development
    • 11.5 Vault Pharma Inc.
      • 11.5.1 Vault Pharma Inc. Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Vault Pharma Inc. Melanocyte Protein PMEL Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Vault Pharma Inc. Melanocyte Protein PMEL Products Offered
      • 11.5.5 Vault Pharma Inc. Recent Development

    12 Future Forecast

    • 12.1 Melanocyte Protein PMEL Market Forecast by Regions
      • 12.1.1 Global Melanocyte Protein PMEL Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Melanocyte Protein PMEL Revenue Forecast by Regions 2019-2025
    • 12.2 Melanocyte Protein PMEL Market Forecast by Product
      • 12.2.1 Global Melanocyte Protein PMEL Sales Forecast by Product 2019-2025
      • 12.2.2 Global Melanocyte Protein PMEL Revenue Forecast by Product 2019-2025
    • 12.3 Melanocyte Protein PMEL Market Forecast by End User
    • 12.4 North America Melanocyte Protein PMEL Forecast
    • 12.5 Europe Melanocyte Protein PMEL Forecast
    • 12.6 Asia Pacific Melanocyte Protein PMEL Forecast
    • 12.7 Central & South America Melanocyte Protein PMEL Forecast
    • 12.8 Middle East and Africa Melanocyte Protein PMEL Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Melanocyte Protein PMEL Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Melanocyte Protein PMEL market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Melanocyte Protein PMEL market based on company, product type, end user and key regions.

      This report studies the global market size of Melanocyte Protein PMEL in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Melanocyte Protein PMEL in these regions.
      This research report categorizes the global Melanocyte Protein PMEL market by top players/brands, region, type and end user. This report also studies the global Melanocyte Protein PMEL market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Antigen Express, Inc.
      ImmunoCellular Therapeutics, Ltd.
      Immunomic Therapeutics, Inc.
      Scancell Holdings Plc
      Vault Pharma Inc.

      Market size by Product
      AE-M vaccine
      SCIB-1
      VPI-121
      Others
      Market size by End User
      Glioblastoma Multiforme
      Melanoma
      Metastatic Melanoma

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Melanocyte Protein PMEL market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Melanocyte Protein PMEL market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Melanocyte Protein PMEL companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Melanocyte Protein PMEL submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Melanocyte Protein PMEL are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Melanocyte Protein PMEL market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now